In this interview we speak with Sarah Earle from the University of Oxford (UK) about her use of GWAS to understand more about Neisseria meningitidis and its transition from an asymptomatic commensal to an invasive pathogen.
In this interview, take a look behind the scenes of a recent Future Microbiology paper on the role of transition metal control in E. coli virulence with author, Jeffrey Henderson.
This study looks at Candida tropicalis, evaluating if radiation used in radiotherapy can cause changes in the virulence potential.
In this piece, the authors give an overview of anti-virulence drugs, designed to selectively target key virulence factors of pathogenic bacteria, and one strategy for new antimicrobials.
Novel research suggests that type III interferon-mediated signalling could play a major role in controlling live-attenuated yellow fever virus infection in mice.
Antivirulence agents represent an attractive alternative to antibiotics. Here, the authors discuss the advantages, and the gaps in antivirulence therapy.
This editorial presents some of the latest evidence to support the antivirulence approach, highlighting at the same time some of the issues that need to be considered when evaluating antivirulence drugs.
Researchers looking at the genome of M. tuberculosis have discovered that HIV co-infection could be influencing how the bacteria are evolving.
Researchers have identified a crucial mechanism by which the chikungunya virus infects host cells and mediates disease severity. This could present a future treatment target for both chikungunya and related viruses.
